Phase 2 Study of CS-1008 in Combination With Chemotherapy (Paclitaxel/Carboplatin) in Locally Advanced or Metastatic Ovarian Cancer.
Phase of Trial: Phase II
Latest Information Update: 14 Aug 2017
At a glance
- Drugs Carboplatin; Paclitaxel; Tigatuzumab
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Sponsors Daiichi Sankyo Inc
- 24 Jul 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 12 Jul 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Nov 2009 Actual initiation date (Sep 2009) added as reported by ClinicalTrials.gov.